1. OC-0278: NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial. (April 2018) Authors: Fokas, E.; Fietkau, R.; Hartmann, A.; Hohenberger, W.; Grützmann, R.; Ghadimi, M.; Liersch, T.; Ströbel, P.; Grabenbauer, G.; Wittekind, C.; Sauer, R.; Kaufmann, M.; Hothorn, T.; Rödel, C. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PV-0325: Tumor Regression Grading in the CAO/ARO/AIO-04 phase 3 trial in locally advanced rectal carcinoma. (May 2017) Authors: Fokas, E.; Ghadimi, M.; Fietkau, R.; Ströbel, P.; Hartmann, A.; Sauer, R.; Liersch, T.; Hothorn, T.; Wittekind, C.; Rödel, C. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗